Results 121 to 130 of about 33,833,464 (200)

Monoclonal Antibodies Accessing the Cytosol of Living Cells and Binding to Polo-Like Kinase 1 Interdomain Linker Affect Mitotic Behavior. [PDF]

Chembiochem
Steyer C, Amé JC, Donzeau M, Shen K, Chiper M, Zuber G.   +5 more
europepmc   +1 more source

Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition. [PDF]

Proc Natl Acad Sci U S A, 2023
Park JE, Kirsch K, Lee H, Oliva P, Ahn JI, Ravishankar H, Zeng Y, Fox SD, Kirby SA, Badhwar P, Andresson T, Jacobson KA, Lee KS.   +12 more
europepmc   +1 more source

Mechanisms of nuclear pore complex disassembly by the mitotic Polo-like kinase 1 (PLK-1) in C. elegans embryos. [PDF]

Sci Adv, 2023
Nkombo Nkoula S, Velez-Aguilera G, Ossareh-Nazari B, Van Hove L, Ayuso C, Legros V, Chevreux G, Thomas L, Seydoux G, Askjaer P, Pintard L.   +10 more
europepmc   +1 more source

Polo-like Kinase 1 Inhibitor GSK461364 [PDF]

, 2020
openaire   +1 more source

Immunoinformatic-guided design of a polo-like kinase 1 (PLK1)-targeted multi-epitope vaccine with preliminary <i>in vitro</i> validation. [PDF]

Front Bioinform
Munieswaran G, Subramani NK, Rajan AP, Manickam V.   +3 more
europepmc   +1 more source

Aurora kinases; polo-like kinase 1 (PLK1; STPK13) [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer

, 2019
Chunhao Lin,1,2,* Shoumin Bai,1,3,* Tao Du,4 Yiming Lai,2 Xianju Chen,5 Shengmeng Peng,2 Xiaoming Ma,2 Wanhua Wu,2 Zhenghui Guo,1,2 Hai Huang1,2 1Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial
Lai Y, Bai S, Lin C, Guo Z, Du T, Peng S, Huang H, Ma X, Chen X, Wu W   +9 more
core  

Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study. [PDF]

Front Oncol
Huang XJ, Mo LH, Wu KJ, He RQ, Li H, Chen G, Liu LM.   +6 more
europepmc   +1 more source

Polo-like kinase-1 mediates hepatitis C virus-induced cell migration, a drug target for liver cancer. [PDF]

Life Sci Alliance, 2023
El-Khobar KE, Tay E, Diefenbach E, Gloss BS, George J, Douglas MW.   +5 more
europepmc   +1 more source

Functional and structural impacts of oncogenic missense variants on human polo-like kinase 1 protein. [PDF]

Front Bioinform
Munieswaran G, Manickam V.
europepmc   +1 more source